DGAT2 and metabolic dysfunction-associated steatotic liver disease: Promoting fatty acid esterification by diacylglycerol O-acyl transferase-2 (DGAT2) stimulates hepatic triglyceride synthesis that can contribute to hepatic steatosis and production of triglyceride-rich very low density lipoproteins (VLDLs), which characterizes NAFLD [12].